Sanofi R&D Head Says India Generics Most Important Used With Branded
This article was originally published in PharmAsia News
Executive Summary
Sanofi's research-and-development chief suggests that although his and other drug makers are turning greater focus to generic drugs, those drugs still rely on innovation first, so he does not see the two sectors as competing.